Logo image of FRSX

FORESIGHT AUTONOMOUS-SP ADR (FRSX) Stock Fundamental Analysis

NASDAQ:FRSX - Nasdaq - US3455232039 - ADR - Currency: USD

0.5537  +0 (+0.67%)

Fundamental Rating

3

FRSX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. FRSX has a great financial health rating, but its profitability evaluates not so good. FRSX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FRSX had negative earnings in the past year.
In the past year FRSX has reported a negative cash flow from operations.
In the past 5 years FRSX always reported negative net income.
In the past 5 years FRSX always reported negative operating cash flow.
FRSX Yearly Net Income VS EBIT VS OCF VS FCFFRSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

FRSX has a worse Return On Assets (-114.29%) than 98.77% of its industry peers.
FRSX has a worse Return On Equity (-183.61%) than 91.36% of its industry peers.
Industry RankSector Rank
ROA -114.29%
ROE -183.61%
ROIC N/A
ROA(3y)-91.84%
ROA(5y)-66.89%
ROE(3y)-126.58%
ROE(5y)-88.71%
ROIC(3y)N/A
ROIC(5y)N/A
FRSX Yearly ROA, ROE, ROICFRSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

FRSX's Gross Margin of 60.55% is amongst the best of the industry. FRSX outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of FRSX has grown nicely.
The Profit Margin and Operating Margin are not available for FRSX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.09%
GM growth 5YN/A
FRSX Yearly Profit, Operating, Gross MarginsFRSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

7

2. Health

2.1 Basic Checks

FRSX does not have a ROIC to compare to the WACC, probably because it is not profitable.
FRSX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FRSX has been increased compared to 5 years ago.
There is no outstanding debt for FRSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FRSX Yearly Shares OutstandingFRSX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FRSX Yearly Total Debt VS Total AssetsFRSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

FRSX has an Altman-Z score of -20.56. This is a bad value and indicates that FRSX is not financially healthy and even has some risk of bankruptcy.
FRSX has a worse Altman-Z score (-20.56) than 97.53% of its industry peers.
There is no outstanding debt for FRSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -20.56
ROIC/WACCN/A
WACC9.02%
FRSX Yearly LT Debt VS Equity VS FCFFRSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 4.50 indicates that FRSX has no problem at all paying its short term obligations.
FRSX's Current ratio of 4.50 is amongst the best of the industry. FRSX outperforms 95.06% of its industry peers.
FRSX has a Quick Ratio of 4.50. This indicates that FRSX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.50, FRSX belongs to the top of the industry, outperforming 95.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.5
Quick Ratio 4.5
FRSX Yearly Current Assets VS Current LiabilitesFRSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

FRSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.01%, which is quite impressive.
Looking at the last year, FRSX shows a very negative growth in Revenue. The Revenue has decreased by -12.27% in the last year.
FRSX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.73% yearly.
EPS 1Y (TTM)57.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.65%
Revenue 1Y (TTM)-12.27%
Revenue growth 3Y53.73%
Revenue growth 5YN/A
Sales Q2Q%-26.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRSX Yearly Revenue VS EstimatesFRSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 100K 200K 300K 400K 500K
FRSX Yearly EPS VS EstimatesFRSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2020 2021 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FRSX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRSX Price Earnings VS Forward Price EarningsFRSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRSX Per share dataFRSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRSX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORESIGHT AUTONOMOUS-SP ADR

NASDAQ:FRSX (5/29/2025, 2:03:09 PM)

0.5537

+0 (+0.67%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change29.67%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap10.76M
Analysts82.86
Price TargetN/A
Short Float %2.09%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24.67
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 1.77
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0.02
BVpS0.31
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -114.29%
ROE -183.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.55%
FCFM N/A
ROA(3y)-91.84%
ROA(5y)-66.89%
ROE(3y)-126.58%
ROE(5y)-88.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.09%
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 14.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.5
Quick Ratio 4.5
Altman-Z -20.56
F-Score3
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)32.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.27%
Revenue growth 3Y53.73%
Revenue growth 5YN/A
Sales Q2Q%-26.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.93%
OCF growth 3YN/A
OCF growth 5YN/A